GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
X

Xbrane Biopharma XBRANE.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

12.25

-3.54%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SEK, from our data supplier.

FY2025

Revenue

SEK 152.4m

FY2016FY2025

Net income

SEK 127.2m

FY2016FY2025

Free cash flow

−SEK 390.3m

FY2016FY2025

Shareholders' equity

SEK 560.7m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueSEK 152.4mSEK 198.7mSEK 238.7mSEK 57.6mSEK 11.5mSEK 6.8mSEK 600,000SEK 113.0mSEK 20.8mSEK 2.5m
Research and developmentSEK 117.9mSEK 312.9mSEK 305.8mSEK 199.6mSEK 160.6mSEK 203.3mSEK 115.7mSEK 85.8mSEK 38.0mSEK 2.9m
Operating income−SEK 72.1m−SEK 217.9m−SEK 310.4m−SEK 166.2m−SEK 180.6m−SEK 225.3m−SEK 164.6m−SEK 11.4m−SEK 44.7m−SEK 33.2m
Net incomeSEK 127.2m−SEK 266.2m−SEK 388.2m−SEK 172.2m−SEK 191.0m−SEK 226.8m−SEK 167.5m−SEK 13.2m−SEK 44.9m−SEK 33.3m
Diluted earnings per share0.27-21.76-184.54-90.33-111.31-159.44-178.39-28.82-106.20-94.70

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsSEK 671.6mSEK 842.4mSEK 653.5mSEK 690.5mSEK 688.4mSEK 463.8mSEK 338.9mSEK 252.9mSEK 111.0mSEK 118.1m
Cash and short-term investmentsSEK 86.6mSEK 124.3mSEK 65.4mSEK 194.0mSEK 295.2mSEK 243.1mSEK 164.2mSEK 101.0mSEK 7.9mSEK 31.3m
Total liabilitiesSEK 111.0mSEK 633.9mSEK 482.2mSEK 265.6mSEK 256.7mSEK 206.1mSEK 154.6mSEK 169.8mSEK 22.6mSEK 10.8m
DebtSEK 58.3mSEK 191.7mSEK 231.5mSEK 38.2mSEK 44.4mSEK 6.3mSEK 9.4mSEK 45.6mSEK 1.1mSEK 1.7m
Shareholders' equitySEK 560.7mSEK 208.5mSEK 171.3mSEK 424.9mSEK 431.7mSEK 257.7mSEK 184.3mSEK 83.1mSEK 88.4mSEK 107.3m
Shares outstanding465m12m2m2m2m1m1m0m0m0m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−SEK 250.7m−SEK 133.7m−SEK 406.7m−SEK 193.9m−SEK 219.6m−SEK 238.4m−SEK 148.6mSEK 46.7m−SEK 36.8m−SEK 39.4m
Capital spending−SEK 139.6m−SEK 52.2m−SEK 16.8m−SEK 60.1m−SEK 77.3m−SEK 3.9m−SEK 1.2m−SEK 1.6m−SEK 3.3m−SEK 12.1m
Free cash flow−SEK 390.3m−SEK 186.0m−SEK 423.4m−SEK 254.0m−SEK 297.0m−SEK 242.3m−SEK 149.8mSEK 45.1m−SEK 40.2m−SEK 51.5m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueSEK 46.8mSEK 17.3mSEK 9.1mSEK 10.1mSEK 39.9mSEK 93.2mSEK 65.9mSEK 66.8m
Operating income−SEK 14.7m−SEK 10.7m−SEK 24.7m−SEK 22.8m−SEK 7.7mSEK 27.7m−SEK 31.7m−SEK 37.4m
Net income−SEK 11.4m−SEK 13.1m−SEK 26.5m−SEK 24.0mSEK 169.6mSEK 8.2m−SEK 53.2m−SEK 45.1m
Diluted earnings per share-0.55-0.63-0.06-0.050.360.02-4.35-3.69
Cash from operations−SEK 4.0m−SEK 8.0m−SEK 67.0m−SEK 49.0m−SEK 65.0m−SEK 68.0mSEK 93.0m−SEK 14.0m
Capital spending—−SEK 10.0m−SEK 139.0m−SEK 144.0m−SEK 48.0m−SEK 24.0m−SEK 17.0m−SEK 23.0m
Free cash flow—−SEK 18.0m−SEK 206.0m−SEK 193.0m−SEK 113.0m−SEK 92.0mSEK 76.0m−SEK 37.0m
Total assetsSEK 642.6mSEK 670.8mSEK 671.6mSEK 701.5mSEK 601.8mSEK 696.3mSEK 842.4mSEK 839.7m
Cash and short-term investmentsSEK 49.5mSEK 66.7mSEK 86.6mSEK 93.6mSEK 5.9mSEK 24.7mSEK 124.3mSEK 30.6m
DebtSEK 60.7mSEK 56.9mSEK 58.3m—SEK 20.0mSEK 149.6mSEK 191.7mSEK 170.4m
Shareholders' equitySEK 538.8mSEK 550.2mSEK 560.7mSEK 587.0mSEK 384.9mSEK 216.3mSEK 208.5mSEK 260.1m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue38.3%86.1%79.7%
Operating income-24.3%-20.4%20.1%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-82.6%-118.4%-176.1%-179.1%
Net margin-39.6%-108.0%-167.8%-172.8%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings37.3-0.6-0.0-0.2-0.2-0.1-0.0-0.3-0.1-0.1
Price to sales31.10.80.10.52.72.79.30.00.20.9

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 125-to-1 reverse split · 17 Oct 2025

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.